Browsing Tag
clinical trial
34 posts
What KT‑621 success could mean for oral immunology drugs and Kymera Therapeutics
Get ready for Kymera Therapeutics' KT‑621 Phase 1b data on December 8. Can this oral eczema drug change the future of immunology?
Phase 2 trial of Nasus Pharma’s NS002 needle-free epinephrine starts with initial dosing milestone
Find out how Nasus Pharma is advancing NS002, its needle-free intranasal epinephrine candidate, into Phase 2 trials and what it means for emergency allergy care.
Investors watch Nuvalent ahead of pivotal neladalkib ALKOVE-1 topline data in resistant ALK-positive NSCLC
Nuvalent will unveil pivotal ALKOVE-1 data for neladalkib in TKI-pretreated ALK-positive NSCLC on November 17. Explore why investors believe this readout could redefine targeted lung cancer care.
FDA lifts hold on Rein Therapeutics’ LTI-03 trial, reviving hopes for idiopathic pulmonary fibrosis treatment
FDA clears Rein Therapeutics to restart its Phase 2 trial of LTI-03 for idiopathic pulmonary fibrosis, restoring investor confidence and trial momentum.
Bioxytran reports successful clinical trial for ProLectin-M, a broad-spectrum antiviral targeting multiple respiratory viruses
Find out how Bioxytran’s completed randomized trial for ProLectin-M could redefine the antiviral market and reshape biotech investor sentiment.
Denifanstat phase 3 acne trial success positions Ascletis for China NDA submission in 2026
Find out how Denifanstat’s Phase 3 acne trial success positions Ascletis Pharma for a 2026 China NDA submission and reshapes the acne-therapy market.
FDA greenlights Envoy Medical’s fully implanted cochlear implant trial — could this be the biggest leap in hearing restoration yet?
Find out how Envoy Medical’s FDA-cleared Acclaim cochlear implant trial is redefining the future of fully implanted hearing technology.
Bonerge initiates clinical trial evaluating Urolithin A and Fisetin for age-related sleep disruptions
Bonerge begins a clinical trial on Urolithin A and Fisetin for sleep quality, marking a shift toward evidence-backed anti-ageing and circadian rhythm restoration.
PharmaJet and Immuno Cure partner to launch needle-free HIV therapeutic DNA vaccine trial using Tropis intradermal device
PharmaJet and Immuno Cure sign agreement to use the Tropis intradermal system in a needle-free human trial for a promising HIV DNA vaccine candidate.
Abbott’s Healthy Food Rx program shows clinical benefits for diabetes patients in low-income settings
Abbott’s Healthy Food Rx clinical trial improves diet, A1C levels, and health in underserved diabetes patients, advancing the food-is-medicine model in the U.S.